-
1
-
-
65549093984
-
Framingham stroke risk function in a large population-based cohort of elderly people: The 3C study
-
Bineau S, Dufouil C, Helmer C, Ritchie K, Empana JP, Ducimetiere P, Alperovitch A, Bousser MG, Tzourio C. Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study. Stroke. 2009;40:1564-1570.
-
(2009)
Stroke
, vol.40
, pp. 1564-1570
-
-
Bineau, S.1
Dufouil, C.2
Helmer, C.3
Ritchie, K.4
Empana, J.P.5
Ducimetiere, P.6
Alperovitch, A.7
Bousser, M.G.8
Tzourio, C.9
-
2
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302:1993-2000.
-
(2009)
JAMA
, vol.302
, pp. 1993-2000
-
-
Di Angelantonio, E.1
Sarwar, N.2
Perry, P.3
Kaptoge, S.4
Ray, K.K.5
Thompson, A.6
Wood, A.M.7
Lewington, S.8
Sattar, N.9
Packard, C.J.10
Collins, R.11
Thompson, S.G.12
Danesh, J.13
-
3
-
-
73849149460
-
Optimizing vascular risk reduction in the stroke patient with atherothrombotic disease
-
Ovbiagele B. Optimizing vascular risk reduction in the stroke patient with atherothrombotic disease. Med Princ Pract. 2010;19:1-12.
-
(2010)
Med Princ Pract.
, vol.19
, pp. 1-12
-
-
Ovbiagele, B.1
-
4
-
-
45849096499
-
Microalbuminuria: Risk factor and potential therapeutic target for stroke?
-
Ovbiagele B. Microalbuminuria: risk factor and potential therapeutic target for stroke? J Neurol Sci. 2008;271:21-28.
-
(2008)
J Neurol Sci
, vol.271
, pp. 21-28
-
-
Ovbiagele, B.1
-
6
-
-
60149109376
-
Proteinuria and stroke: A meta-analysis of cohort studies
-
Ninomiya T, Perkovic V, Verdon C, Barzi F, Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC, Huxley R. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis. 2009;53:417-425.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 417-425
-
-
Ninomiya, T.1
Perkovic, V.2
Verdon, C.3
Barzi, F.4
Cass, A.5
Gallagher, M.6
Jardine, M.7
Anderson, C.8
Chalmers, J.9
Craig, J.C.10
Huxley, R.11
-
7
-
-
0034685429
-
Meta-analysis of observational studies in epidemiology: A proposal for reporting
-
Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
-
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283:2008-2012.
-
(2000)
JAMA
, vol.283
, pp. 2008-2012
-
-
Stroup, D.F.1
Berlin, J.A.2
Morton, S.C.3
Olkin, I.4
Williamson, G.D.5
Rennie, D.6
Moher, D.7
Becker, B.J.8
Sipe, T.A.9
Thacker, S.B.10
-
8
-
-
0242441465
-
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
DOI 10.1161/01.HYP.0000102971.85504.7c
-
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42:1050-1065. (Pubitemid 37413751)
-
(2003)
Hypertension
, vol.42
, Issue.5
, pp. 1050-1065
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
Coresh, J.4
Culleton, B.5
Hamm, L.L.6
McCullough, P.A.7
Kasiske, B.L.8
Kelepouris, E.9
Klag, M.J.10
Parfrey, P.11
Pfeffer, M.12
Raij, L.13
Spinosa, D.J.14
Wilson, P.W.15
-
10
-
-
0037098199
-
Quantifying heterogeneity in a meta-analysis
-
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
-
(2002)
Stat Med
, vol.21
, pp. 1539-1558
-
-
Higgins, J.P.1
Thompson, S.G.2
-
13
-
-
0041416271
-
Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: The Fremantle Diabetes Study
-
Gillett M, Davis WA, Jackson D, Bruce DG, Davis TM. Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: the Fremantle Diabetes Study. Stroke. 2003;34:2145-2151.
-
(2003)
Stroke
, vol.34
, pp. 2145-2151
-
-
Gillett, M.1
Davis, W.A.2
Jackson, D.3
Bruce, D.G.4
Davis, T.M.5
-
14
-
-
36549089969
-
Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS)
-
Hitman GA, Colhoun H, Newman C, Szarek M, Betteridge DJ, Durrington PN, Fuller J, Livingstone S, Neil HA. Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabet Med. 2007;24:1313-1321.
-
(2007)
Diabet Med
, vol.24
, pp. 1313-1321
-
-
Hitman, G.A.1
Colhoun, H.2
Newman, C.3
Szarek, M.4
Betteridge, D.J.5
Durrington, P.N.6
Fuller, J.7
Livingstone, S.8
Neil, H.A.9
-
15
-
-
15944419583
-
N-terminal pro-brain natriuretic peptide C-reactive protein and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
-
Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005;293:1609-1616.
-
(2005)
JAMA
, vol.293
, pp. 1609-1616
-
-
Kistorp, C.1
Raymond, I.2
Pedersen, F.3
Gustafsson, F.4
Faber, J.5
Hildebrandt, P.6
-
16
-
-
0029834054
-
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects
-
Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 1996;27:2033-2039.
-
(1996)
Stroke
, vol.27
, pp. 2033-2039
-
-
Miettinen, H.1
Haffner, S.M.2
Lehto, S.3
Ronnemaa, T.4
Pyorala, K.5
Laakso, M.6
-
17
-
-
32944464800
-
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: Final results of a prospective long-term study (MARPLE Study)
-
Schrader J, Luders S, Kulschewski A, Hammersen F, Zuchner C, Ven-neklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens. 2006;24:541-548.
-
(2006)
J Hypertens
, vol.24
, pp. 541-548
-
-
Schrader, J.1
Luders, S.2
Kulschewski, A.3
Hammersen, F.4
Zuchner, C.5
Ven-Neklaas, U.6
Schrandt, G.7
Schnieders, M.8
Rangoonwala, B.9
Berger, J.10
Dominiak, P.11
Zidek, W.12
-
18
-
-
65649145291
-
Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
-
Solbu MD, Kronborg J, Jenssen TG, Njolstad I, Lochen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis. 2009;204:503-508.
-
(2009)
Atherosclerosis
, vol.204
, pp. 503-508
-
-
Solbu, M.D.1
Kronborg, J.2
Jenssen, T.G.3
Njolstad, I.4
Lochen, M.L.5
Mathiesen, E.B.6
Wilsgaard, T.7
Eriksen, B.O.8
Toft, I.9
-
19
-
-
0034708947
-
The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus
-
Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000; 160:1093-1100.
-
(2000)
Arch Intern Med
, vol.160
, pp. 1093-1100
-
-
Valmadrid, C.T.1
Klein, R.2
Moss, S.E.3
Klein, B.E.4
-
20
-
-
64349101448
-
Additive interaction of hyperglycemia and albumin-uria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry
-
Yang X, Ko GT, So WY, Ma RC, Kong AP, Lam CW, Ho CS, Chow CC, Tong PC, Chan JC. Additive interaction of hyperglycemia and albumin-uria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry. Diabetes Care. 2008;31:2294-2300.
-
(2008)
Diabetes Care
, vol.31
, pp. 2294-2300
-
-
Yang, X.1
Ko, G.T.2
So, W.Y.3
Ma, R.C.4
Kong, A.P.5
Lam, C.W.6
Ho, C.S.7
Chow, C.C.8
Tong, P.C.9
Chan, J.C.10
-
21
-
-
58149280400
-
Albuminuria, but not metabolic syndrome, is a significant predictor of stroke recurrence in ischemic stroke
-
Yokota C, Minematsu K, Ito A, Toyoda K, Nagasawa H, Yamaguchi T. Albuminuria, but not metabolic syndrome, is a significant predictor of stroke recurrence in ischemic stroke. J Neurol Sci. 2009;277:50-53.
-
(2009)
J Neurol Sci
, vol.277
, pp. 50-53
-
-
Yokota, C.1
Minematsu, K.2
Ito, A.3
Toyoda, K.4
Nagasawa, H.5
Yamaguchi, T.6
-
22
-
-
1242340400
-
Microalbuminuria and stroke in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
-
Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med. 2004;255:247-256.
-
(2004)
J Intern Med
, vol.255
, pp. 247-256
-
-
Yuyun, M.F.1
Khaw, K.T.2
Luben, R.3
Welch, A.4
Bingham, S.5
Day, N.E.6
Wareham, N.J.7
-
23
-
-
55249106874
-
Incidence and risk factors for stroke in American Indians: The Strong Heart Study
-
Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, Kizer JR, Howard BV, Cowan LD, Yeh J, Howard WJ, Wang W, Best L, Lee ET. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation. 2008;118:1577-1584.
-
(2008)
Circulation
, vol.118
, pp. 1577-1584
-
-
Zhang, Y.1
Galloway, J.M.2
Welty, T.K.3
Wiebers, D.O.4
Whisnant, J.P.5
Devereux, R.B.6
Kizer, J.R.7
Howard, B.V.8
Cowan, L.D.9
Yeh, J.10
Howard, W.J.11
Wang, W.12
Best, L.13
Lee, E.T.14
-
25
-
-
69249135116
-
Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey
-
Tebbe U, Bramlage P, Thoenes M, Paar WD, Danchin N, Volpe M, Schrader J, Noll G, Burnier M, Bohm M. Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. Swiss Med Wkly. 2009;139:473-480.
-
(2009)
Swiss Med Wkly
, vol.139
, pp. 473-480
-
-
Tebbe, U.1
Bramlage, P.2
Thoenes, M.3
Paar, W.D.4
Danchin, N.5
Volpe, M.6
Schrader, J.7
Noll, G.8
Burnier, M.9
Bohm, M.10
-
26
-
-
19944432108
-
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study
-
DOI 10.1161/01.HYP.0000154082.72286.2a
-
Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45:198-202. (Pubitemid 40179960)
-
(2005)
Hypertension
, vol.45
, Issue.2
, pp. 198-202
-
-
Ibsen, H.1
Olsen, M.H.2
Wachtell, K.3
Borch-Johnsen, K.4
Lindholm, L.H.5
Mogensen, C.E.6
Dahlof, B.7
Devereux, R.B.8
De Faire, U.9
Fyhrquist, F.10
Julius, S.11
Kjeldsen, S.E.12
Lederballe-Pedersen, O.13
Nieminen, M.S.14
Omvik, P.15
Oparil, S.16
Wan, Y.17
-
27
-
-
0037031270
-
Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect
-
Viberti G, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation. 2002;106:672-678.
-
(2002)
Circulation
, vol.106
, pp. 672-678
-
-
Viberti, G.1
Wheeldon, N.M.2
-
28
-
-
7444221237
-
Preventing microal-buminuria in type 2 diabetes
-
Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B, Gaspari F, Perna A, Bossi A, Trevisan R, Dodesini AR, Remuzzi G. Preventing microal-buminuria in type 2 diabetes. N Engl J Med. 2004;351:1941-1951.
-
(2004)
N Engl J Med
, vol.351
, pp. 1941-1951
-
-
Ruggenenti, P.1
Fassi, A.2
Ilieva, A.P.3
Bruno, S.4
Iliev, I.P.5
Brusegan, V.6
Rubis, N.7
Gherardi, G.8
Arnoldi, F.9
Ganeva, M.10
Ene-Iordache, B.11
Gaspari, F.12
Perna, A.13
Bossi, A.14
Trevisan, R.15
Dodesini, A.R.16
Remuzzi, G.17
-
29
-
-
8144224441
-
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria
-
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004;110:2809-2816.
-
(2004)
Circulation
, vol.110
, pp. 2809-2816
-
-
Asselbergs, F.W.1
Diercks, G.F.2
Hillege, H.L.3
Van Boven, A.J.4
Janssen, W.M.5
Voors, A.A.6
De Zeeuw, D.7
De Jong, P.E.8
Van Veldhuisen, D.J.9
Van Gilst, W.H.10
-
30
-
-
33750250280
-
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients
-
Van De Wal RM, Gansevoort RT, Van Der Harst P, Boomsma F, Thijs Plokker HW, Van Veldhuisen DJ, De Jong PE, Van Gilst WH, Voors AA. Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients. Hypertension. 2006; 48:870-876.
-
(2006)
Hypertension
, vol.48
, pp. 870-876
-
-
Van De Wal, R.M.1
Gansevoort, R.T.2
Van Der Harst, P.3
Boomsma, F.4
Thijs Plokker, H.W.5
Van Veldhuisen, D.J.6
De Jong, P.E.7
Van Gilst, W.H.8
Voors, A.A.9
-
31
-
-
33745104728
-
Pharmacoeconomics of angio-tensin II antagonists in type 2 diabetic patients with nephropathy: Implications for decision making
-
Boersma C, Atthobari J, Gansevoort RT, de Jong-Van den Berg LT, de Jong PE, de Zeeuw D, Annemans LJ, Postma MJ. Pharmacoeconomics of angio-tensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making. Pharmacoeconomics. 2006;24:523-535.
-
(2006)
Pharmacoeconomics
, vol.24
, pp. 523-535
-
-
Boersma, C.1
Atthobari, J.2
Gansevoort, R.T.3
De Jong-Van Den Berg, L.T.4
De Jong, P.E.5
De Zeeuw, D.6
Annemans, L.J.7
Postma, M.J.8
-
32
-
-
42949118875
-
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
-
Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrol Dial Transplant. 2008;23:1216-1223.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 1216-1223
-
-
Palmer, A.J.1
Valentine, W.J.2
Chen, R.3
Mehin, N.4
Gabriel, S.5
Bregman, B.6
Rodby, R.A.7
-
33
-
-
0032704205
-
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors
-
Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med. 1999;131:660-667.
-
(1999)
Ann Intern Med
, vol.131
, pp. 660-667
-
-
Golan, L.1
Birkmeyer, J.D.2
Welch, H.G.3
-
34
-
-
0346749771
-
Screening for proteinuria in US adults: A cost-effectiveness analysis
-
Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290:3101-3114.
-
(2003)
JAMA
, vol.290
, pp. 3101-3114
-
-
Boulware, L.E.1
Jaar, B.G.2
Tarver-Carr, M.E.3
Brancati, F.L.4
Powe, N.R.5
-
35
-
-
12144291002
-
Cost-effectiveness of screening for proteinuria
-
author reply 1443
-
Gansevoort RT, de Jong PE, Postma MJ. Cost-effectiveness of screening for proteinuria. JAMA. 2004;291:1442-1443; author reply 1443.
-
(2004)
JAMA
, vol.291
, pp. 1442-1443
-
-
Gansevoort, R.T.1
De Jong, P.E.2
Postma, M.J.3
-
36
-
-
33646350385
-
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
-
Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: a pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther. 2006;28:432-444.
-
(2006)
Clin Ther
, vol.28
, pp. 432-444
-
-
Atthobari, J.1
Asselbergs, F.W.2
Boersma, C.3
De Vries, R.4
Hillege, H.L.5
Van Gilst, W.H.6
Gansevoort, R.T.7
Den Jong-Van De Pe D.Jong8
Berg, L.T.9
Postma, M.J.10
-
37
-
-
0033599964
-
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29
-
Davis TM, Millns H, Stratton IM, Holman RR, Turner RC. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med. 1999;159:1097-1103.
-
(1999)
Arch Intern Med
, vol.159
, pp. 1097-1103
-
-
Davis, T.M.1
Millns, H.2
Stratton, I.M.3
Holman, R.R.4
Turner, R.C.5
|